CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
CHEMED CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$508.29−4.09 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $6.71B
- P/E (TTM)
- 25.5
- Dividend yield
- 0.43%
Share price
+$67.73 (+15.37%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
CHEMED CORP grew revenue 3.3% to $2.60B over the twelve months to Jun 30, 2026. Operating income fell 5.3% to $349.19M, moving the operating margin from 14.7% to 13.5%. Free cash flow was $323.47M, down 11.7% from a year earlier.
Revenue
$2.60B
+3.3% vs. a year earlier
Operating income
$349.19M
-5.3% vs. a year earlier
Free cash flow
$323.47M
-11.7% vs. a year earlier
EPS, diluted
$19.92
+2.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $6.71B
- P/E ratio
- 25.5
- Price to sales
- 2.59
- Price to book
- 8.08
- Dividend yield
- 0.43%
- Free cash flow yield
- 4.82%
Fundamentals
- Revenue
- $2.60B
- Net income
- $274.99M
- EPS, diluted
- $19.92
- Free cash flow
- $323.47M
- Book value per share
- $62.92
- Diluted shares
- 13M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.60B+3.3% YoY
Gross profit
$859.31M+1.7% YoY
Operating income
$349.19M-5.3% YoY
Net income
$274.99M-5.3% YoY
EPS, diluted
$19.92+2.4% YoY
Free cash flow
$323.47M-11.7% YoY
Reported periodTrailing twelve months